GCL
FPRX

Glazer Capital LLC’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Glazer Capital LLC’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-211,079
Closed -$7.95M – 1082
2021
Q1 		$7.95M Buy
+211,079
New +$7.95M 0.11% 250